Hematología. Trasplante Hematopoyético y Terapia Celular
Centro de Investigación Biomédica en Red sobre Enfermedades Raras
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Raras (14)
2024
-
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 64-92
-
Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder
Clinical Genetics, Vol. 105, Núm. 2, pp. 140-149
-
Identification of copy-number variants in patients with overgrowth disorders
Clinical Genetics, Vol. 106, Núm. 5, pp. 614-624
-
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
HemaSphere, Vol. 8, Núm. 2
2023
-
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)
Frontiers in Pediatrics, Vol. 11
-
ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome
EMBO Molecular Medicine, Vol. 15, Núm. 10
2022
-
Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis
Hematology Reports, Vol. 14, Núm. 4, pp. 300-304
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
-
Enforced mesenchymal stem cell tissue colonization counteracts immunopathology
npj Regenerative Medicine, Vol. 7, Núm. 1
-
New Insights Into Pathophysiology of β-Thalassemia
Frontiers in Medicine, Vol. 9
2020
-
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 2
-
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
Frontiers in Pediatrics, Vol. 8